Want to see RGNX full AI Analyst Report?
RegenXBio (RGNX) Income Statement
RegenXBio Income Statement
Last quarter (Q2 2026), RegenXBio's total revenue was $108.02M, an increase of 405.73% from the same quarter last year. In Q2, RegenXBio's net income was $22.71M. See RegenXBio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 170.44M | $ 83.33M | $ 90.24M | $ 112.72M | $ 470.35M | |
| $ 150.14M | $ 49.76M | $ 53.03M | $ 58.18M | $ 418.51M | |
| $ 311.34M | $ 283.11M | $ 321.16M | $ 321.06M | $ 258.53M | |
| Depreciation and Amortization | $ 15.62M | $ 16.21M | $ 17.32M | $ 12.91M | $ 9.56M |
| $ -133.25M | $ -198.23M | $ -239.46M | $ -244.24M | $ 177.09M | |
| $ -161.20M | $ -233.35M | $ -268.13M | $ -262.88M | $ 159.98M | |
| $ -32.68M | $ 6.24M | $ 4.48M | $ -17.53M | $ -18.73M | |
| $ -193.88M | $ -227.10M | $ -263.65M | $ -280.40M | $ 141.25M | |
| $ -193.88M | $ -227.10M | $ -263.49M | $ -280.32M | $ 127.84M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.76 | $ -4.59 | $ -6.02 | $ -6.50 | $ 3.01 |
| Diluted EPS | $ -3.76 | $ -4.59 | $ -6.02 | $ -6.50 | $ 2.91 |
| Weighted Average Shares Outstanding | 51.57M | 49.51M | 43.73M | 43.15M | 42.44M |
| Weighted Average Shares Outstanding (Diluted) | 51.57M | 49.51M | 43.73M | 43.15M | 43.91M |
Currency in USD